Key points are not available for this paper at this time.
Policymakers often consider interventions at the scale of the population, or some other large scale. One of the sources of information about the potential effects of such interventions is experimental studies conducted at a significantly smaller scale. A common occurrence is for the treatment effects detected in these small-scale studies to diminish substantially in size when applied at the larger scale that is of interest to policymakers. This paper provides an overview of the main reasons for a breakdown in scalability. Understanding the principal mechanisms represents a first step toward formulating countermeasures that promote scalability.
Al‐Ubaydli et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: